Sally atef

and Sally A. Mohamed, Tamer I. Mahmoud, A. S. A. A. A. S., " Assessment of the Protective Effect of the Humoral Immune Response against Major Moraxella catarrhalis Surface Antigens on Otitis Media Manifestation in Egyptian Children", IMED 2021 conference, the 8th international meeting on emerging diseases and surveillance (IMED), November, 2021.

and Sally A. Mohamed, Tamer I. Mahmoud, A. S. A. A. A. S., "Genetic and Phenotypic Characterization of Moraxella catarrhalis strains isolated from Egyptian otitis media children", TWAS/BioVision Alexandria. NXT 2014, Alexandria, Egypt., Egypt, April, 2014.

Aziz, D., S. A. Mohamed, S. Tayel, and A. Makhlouf, "Flexosomes as a promising nanoplatform for enhancing tolnaftate ocular delivery: Formulation, in vitro characterization, statistical optimization, ex vivo and microbial in vivo studies", International Journal of Pharmaceutics, vol. 646, pp. 1-12, 2023.

Mohamed Y Zakaria, Walaa A Eraqi, S. M. A., "Ultra-deformable free fatty acid based nano-carriers for topical delivery of Luteolin: A potential paradigm for management of Methicillin-Resistant Staphylococcus aureus skin infections", International Journal of Pharmaceutics, vol. 643, pp. 1-13, 2023.

, "A Novel Surface-Exposed Polypeptide Is Successfully Employed as a Target for Developing a Prototype One-Step Immunochromatographic Strip for Specific and Sensitive Direct Detection of Staphylococcus aureus Causing Neonatal Sepsis", Biomolecules, vol. 10, issue 11, pp. 1-14, 2020.

Aziz, D., S. A. Mohamed, S. Tayel, and A. Makhlouf, "Implementing polymeric pseudorotaxanes for boosting corneal permeability and antiaspergillus activity of tolnaftate: formulation development, statistical optimization, ex vivo permeation and in vivo assessment", Drug delivery, vol. 29, issue 1, pp. 2162–2176, 2022.

Aziz, D., S. A. Mohamed, S. Tayel, and A. Makhlouf, "Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study", Pharmaceutics, vol. 14, issue 8, pp. 1-21, 2022.